Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4247346
Max Phase: Preclinical
Molecular Formula: C22H14N4
Molecular Weight: 334.38
Molecule Type: Small molecule
Associated Items:
ID: ALA4247346
Max Phase: Preclinical
Molecular Formula: C22H14N4
Molecular Weight: 334.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: c1ccc2c(c1)c1ccncc1n2-n1c2ccccc2c2ccncc21
Standard InChI: InChI=1S/C22H14N4/c1-3-7-19-15(5-1)17-9-11-23-13-21(17)25(19)26-20-8-4-2-6-16(20)18-10-12-24-14-22(18)26/h1-14H
Standard InChI Key: XAJANKHEYZUOPN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 334.38 | Molecular Weight (Monoisotopic): 334.1218 | AlogP: 5.00 | #Rotatable Bonds: 1 |
Polar Surface Area: 35.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 5.16 | CX LogP: 2.85 | CX LogD: 2.85 |
Aromatic Rings: 6 | Heavy Atoms: 26 | QED Weighted: 0.42 | Np Likeness Score: -0.36 |
1. Suzuki K, Nomura I, Ninomiya M, Tanaka K, Koketsu M.. (2018) Synthesis and antimicrobial activity of β-carboline derivatives with N2-alkyl modifications., 28 (17): [PMID:30001916] [10.1016/j.bmcl.2018.06.050] |
2. Dai JK, Dan WJ, Wan JB.. (2022) Natural and synthetic β-carboline as a privileged antifungal scaffolds., 229 [PMID:34954591] [10.1016/j.ejmech.2021.114057] |
Source(1):